Search for:

Search Medicine or Company Name Search Full Document

Advanced Search

Document information 02/09/2010 15:22

Current documents
	4122
	3493
Total:	7615

Submissions in the last 3 months
Updated:	1443
New:	511

What's New

These are the latest new, updated and retired (removed) Summaries of Product Characteristics (known as SPCs or SmPCs) and Patient Information Leaflets (known as PILs, Package Leaflets or PLs) on the eMC website. More help.

Filter Results

Document Type:

Date Range :

Status:

02 September 2010 New 4, Updated 36, Retired 0, [Total 40]
Agrippal Active Ingredients / Generics: influenza vaccine (surface antigen, inactivated) Company: Novartis Vaccines \| Document History Change to section 2 - Qualitative and quantitative composition Change to section 10 date of revision of the text
Beechams Active Cold Relief Caplets Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams All in One Liquid (P) Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin Company: GlaxoSmithKline Consumer Healthcare New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Beechams All-in-One Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.7 - Effects on Ability to Drive and Use Machines Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams All-In-One Tablets Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams All-In-One Tablets (24s, P) Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams Cold & Flu Hot Lemon and Honey Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c) Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams Cold and Flu Hot Blackcurrant Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c) Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams Decongestant Plus With Paracetamol Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams Flu Plus Hot Lemon Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c) Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams Flu-Plus Caplets Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams Flu-Plus Hot Berry Fruits Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c) Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Beechams Powders Capsules Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 10 date of revision of the text
Begrivac 2010/2011 suspension for injection in pre-filled syringe Active Ingredients / Generics: influenza vaccine Company: Novartis Vaccines \| Document History Change to section 2 - Qualitative and quantitative composition Change to section 10 date of revision of the text
Calcichew 500mg Chewable Tablets Active Ingredients / Generics: calcium carbonate Company: Shire Pharmaceuticals Limited \| Document History Change to side-effects Change to drug interactions
Calcichew D3 Chewable Tablets Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3) Company: Shire Pharmaceuticals Limited \| Document History Change to date of revision Change to side-effects Change to drug interactions
Calcichew D3 Forte Chewable Tablets Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3) Company: Shire Pharmaceuticals Limited \| Document History Change to side-effects Change to drug interactions
Calcichew Forte Chewable Tablets Active Ingredients / Generics: calcium carbonate Company: Shire Pharmaceuticals Limited \| Document History Change to date of revision Change to side-effects Change to drug interactions
Captopril 50mg Tablets Active Ingredients / Generics: captopril Company: Goldshield plc \| Document History Change to section 4.9 - Overdose
DAKTARIN Sugar Free 2% Oral Gel Active Ingredients / Generics: miconazole Company: McNeil Ltd \| Document History Change to section 4.8 - Undesirable Effects Change to section 10 date of revision of the text
Dihydrocodeine 30mg tablets Active Ingredients / Generics: dihydrocodeine tartrate Company: Goldshield plc New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Dispersible Aspirin 75mg Tablets Active Ingredients / Generics: aspirin Company: Goldshield plc \| Document History Change to section 4.3 - Contraindications Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.6 - Pregnancy and Lactation Change to section 4.8 - Undesirable Effects
Duphalac Active Ingredients / Generics: lactulose Company: Solvay Healthcare Limited \| Document History Change to section 4.4 - Special warnings and precautions for Use Change to section 4.6 - Pregnancy and Lactation Change to section 5.3 - Preclinical Safety Data
Fluvirin Active Ingredients / Generics: influenza vaccine (surface antigen, inactivated) Company: Novartis Vaccines \| Document History Change to section 2 - Qualitative and quantitative composition Change to section 10 date of revision of the text
Furosemide Tablets 500mg Active Ingredients / Generics: furosemide Company: Goldshield plc \| Document History Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties
GARDASIL Active Ingredients / Generics: human papillomavirus vaccine Company: Sanofi Pasteur MSD Limited \| Document History Change to, or new, use for medicine
Haloperidol Injection BP 5mg/ml Active Ingredients / Generics: haloperidol Company: Goldshield plc \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.6 - Pregnancy and Lactation Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose
Helixate NexGen Active Ingredients / Generics: octocog alfa Company: CSL Behring UK Limited \| Document History Change to section 1 -Name of the Medicinal product Change to section 2 - Qualitative and quantitative composition Change to section 3 - Pharmaceutical form Change to section 4.2 - Posology and method of administration Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.6 - Pregnancy and Lactation Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 5.1 - Pharmacodynamic Properties Change to section 6. 4 - Special Precautions for Storage Change to section 6. 5 - Nature and Contents of Container Change to section 6. 6 - Instructions for use, handling and disposal Change to section 9 - Date of first Authorisation/renewal of the Authorisation Change to section 10 date of revision of the text
INTANZA 9 microgram/strain Active Ingredients / Generics: influenza vaccine (split virion, inactivated) Company: Sanofi Pasteur MSD Limited New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Intrinsa 300 micrograms/24 hours transdermal patch Active Ingredients / Generics: testosterone Company: Warner Chilcott UK Limited \| Document History Change to section 7 - Marketing Authorisation Holder Change to section 10 date of revision of the text
Metoclopramide 10mg Tablets Active Ingredients / Generics: metoclopramide hydrochloride Company: Goldshield plc New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Nexavar 200mg film-coated tablets Active Ingredients / Generics: sorafenib tosilate Company: Bayer plc \| Document History Change to section 2 - Qualitative and quantitative composition Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for Use Change to section 4.6 - Pregnancy and Lactation Change to section 4.8 - Undesirable Effects Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties Change to section 6.1 - List of Excipients Change to section 6. 6 - Instructions for use, handling and disposal Change to section 10 date of revision of the text
Ondansetron 4mg film-coated tablets Active Ingredients / Generics: ondansetron hydrochloride dihydrate Company: Goldshield plc \| Document History Change to section 4.1 - Therapeutic indications Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for Use Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties
Ondansetron 8mg film-coated tablets Active Ingredients / Generics: ondansetron hydrochloride dihydrate Company: Goldshield plc \| Document History Change to section 4.1 - Therapeutic indications Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for Use Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties
Pandemrix suspension and emulsion for emulsion for injection Active Ingredients / Generics: influenza vaccine (split virion, inactivated) Company: GlaxoSmithKline UK \| Document History Correction of spelling/typing errors
Slozem 120mg, 180mg, 240mg, 300mg Capsules Active Ingredients / Generics: diltiazem hydrochloride Company: Merck Serono \| Document History Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects
Solpadeine Plus Tablets Active Ingredients / Generics: paracetamol, caffeine, codeine phosphate hemihydrate Company: GlaxoSmithKline Consumer Healthcare \| Document History Change to section 6.1 - List of Excipients Change to section 10 date of revision of the text
Tarceva 25mg, 100mg and 150mg Film-Coated Tablets Active Ingredients / Generics: erlotinib hydrochloride Company: Roche Products Limited \| Document History Change to section 6. 3 - Shelf Life Change to section 10 date of revision of the text
Warfarin 1, 3 & 5mg tablets Active Ingredients / Generics: warfarin sodium Company: Goldshield plc \| Document History Change to date of revision Change of manufacturer Change of contra-indications Change to side-effects Change to drug interactions Change to information about pregnancy or lactation Change to name of manufacturer
Zinacef Active Ingredients / Generics: cefuroxime sodium Company: GlaxoSmithKline UK \| Document History Change to date of revision Change to warnings or special precautions for use Change due to user-testing of patient information
01 September 2010 New 0, Updated 31, Retired 0, [Total 31]
Bricanyl Respules 2.5 mg/ml Nebuliser Solution Active Ingredients / Generics: terbutaline sulphate Company: AstraZeneca UK Limited \| Document History Correction of spelling/typing errors
Calcichew 500mg Chewable Tablets Active Ingredients / Generics: calcium carbonate Company: Shire Pharmaceuticals Limited \| Document History Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose
Calcichew D3 Chewable Tablets Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3) Company: Shire Pharmaceuticals Limited \| Document History Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose
Calcichew D3 Forte Chewable Tablets Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3) Company: Shire Pharmaceuticals Limited \| Document History Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose
Calcichew Forte Chewable Tablets Active Ingredients / Generics: calcium carbonate Company: Shire Pharmaceuticals Limited \| Document History Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose
Clomid Active Ingredients / Generics: clomifene citrate Company: sanofi-aventis \| Document History Change to side-effects
Clomid Active Ingredients / Generics: clomifene citrate Company: sanofi-aventis \| Document History Change to section 4.4 - Special warnings and precautions for Use Change to section 4.8 - Undesirable Effects
Daktarin Oral Gel Active Ingredients / Generics: miconazole Company: Janssen-Cilag Ltd \| Document History Change to section 4.8 - Undesirable Effects Change to section 10 date of revision of the text
Daunorubicin Active Ingredients / Generics: daunorubicin hydrochloride Company: Winthrop Pharmaceuticals UK Ltd \| Document History Change to side-effects Change to drug interactions Change to information about pregnancy or lactation Change to information about driving or using machinery
Daunorubicin Active Ingredients / Generics: daunorubicin hydrochloride Company: Winthrop Pharmaceuticals UK Ltd \| Document History Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.6 - Pregnancy and Lactation Change to section 4.7 - Effects on Ability to Drive and Use Machines Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose
DULCOLAX Suppositories, 10 mg Active Ingredients / Generics: bisacodyl Company: Boehringer Ingelheim Limited Consumer Healthcare \| Document History Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties Change to section 10 date of revision of the text
DULCOLAX Tablets, 5 mg (GSL) Active Ingredients / Generics: bisacodyl Company: Boehringer Ingelheim Limited Consumer Healthcare \| Document History Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties Change to section 10 date of revision of the text
DULCOLAX Tablets, 5mg Active Ingredients / Generics: bisacodyl Company: Boehringer Ingelheim Limited Consumer Healthcare \| Document History Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties Change to section 10 date of revision of the text
GARDASIL Active Ingredients / Generics: human papillomavirus vaccine Company: Sanofi Pasteur MSD Limited \| Document History Change to section 4.1 - Therapeutic indications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.6 - Pregnancy and Lactation Change to section 5.1 - Pharmacodynamic Properties
Kivexa film-coated tablets Active Ingredients / Generics: lamivudine, abacavir sulfate Company: ViiV Healthcare UK Ltd \| Document History Change to Marketing Authorisation Holder Change to manufacturer contact details
Loestrin 20 Active Ingredients / Generics: ethinylestradiol, norethisterone acetate Company: Galen Limited \| Document History Change to section 4.4 - Special warnings and precautions for Use
Loestrin 30 Active Ingredients / Generics: ethinylestradiol, norethisterone acetate Company: Galen Limited \| Document History Change to section 4.4 - Special warnings and precautions for Use
Nexavar 200mg film-coated tablets Active Ingredients / Generics: sorafenib tosilate Company: Bayer plc \| Document History Change to date of revision Change to warnings or special precautions for use Change of contra-indications Change to side-effects, Extra statutory information
Perinal Cutaneous Spray Active Ingredients / Generics: hydrocortisone, lidocaine hydrochloride Company: Dermal Laboratories Limited \| Document History Change to section 9 - Date of first Authorisation/renewal of the Authorisation Change to section 10 date of revision of the text
Priadel 200mg & 400mg prolonged release tablets Active Ingredients / Generics: lithium carbonate Company: sanofi-aventis \| Document History Change to section 5.2 - Pharmacokinetic Properties
Priadel Liquid Active Ingredients / Generics: lithium citrate Company: sanofi-aventis \| Document History Change to section 5.2 - Pharmacokinetic Properties
Resolor 1mg and 2mg film-coated tablets Active Ingredients / Generics: prucalopride succinate Company: Movetis Ltd \| Document History Change to Further Information section Change to date of revision Change to manufacturer contact details
Resolor 1mg film-coated tablets Active Ingredients / Generics: prucalopride succinate Company: Movetis Ltd \| Document History Change to section 6. 5 - Nature and Contents of Container Change to section 7 - Marketing Authorisation Holder Change to section 8 - MARKETING AUTHORISATION NUMBER(S) Change to section 10 date of revision of the text
Resolor 2mg film-coated tablets Active Ingredients / Generics: prucalopride succinate Company: Movetis Ltd \| Document History Change to section 6. 5 - Nature and Contents of Container Change to section 7 - Marketing Authorisation Holder Change to section 8 - MARKETING AUTHORISATION NUMBER(S) Change to section 10 date of revision of the text
Scheriproct Ointment Active Ingredients / Generics: prednisolone hexanoate, cinchocaine hydrochloride Company: Bayer plc \| Document History Removal/change of distributor
Scheriproct Suppositories Active Ingredients / Generics: prednisolone hexanoate, cinchocaine hydrochloride Company: Bayer plc \| Document History Removal/change of distributor
Skinoren Cream Active Ingredients / Generics: azelaic acid Company: Bayer plc \| Document History Removal/change of distributor
Ultrabase Active Ingredients / Generics: No Active Ingredients Company: Bayer plc \| Document History Removal/change of distributor
Vascace Tablets Active Ingredients / Generics: cilazapril monohydrate Company: Roche Products Limited \| Document History Change to section 4.1 - Therapeutic indications Change to section 4.2 - Posology and method of administration Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.6 - Pregnancy and Lactation Change to section 4.7 - Effects on Ability to Drive and Use Machines Change to section 4.8 - Undesirable Effects Change to section 4.9 - Overdose Change to section 5.1 - Pharmacodynamic Properties Change to section 5.3 - Preclinical Safety Data
Zeffix 100mg film-coated tablets Active Ingredients / Generics: lamivudine Company: GlaxoSmithKline UK \| Document History Change to section 4.1 - Therapeutic indications Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.6 - Pregnancy and Lactation Change to section 5.1 - Pharmacodynamic Properties Change to section 9 - Date of first Authorisation/renewal of the Authorisation Change to section 10 date of revision of the text
Zeffix 5mg/ml oral solution Active Ingredients / Generics: lamivudine Company: GlaxoSmithKline UK \| Document History Change to section 4.1 - Therapeutic indications Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for Use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.6 - Pregnancy and Lactation Change to section 5.1 - Pharmacodynamic Properties Change to section 9 - Date of first Authorisation/renewal of the Authorisation Change to section 10 date of revision of the text
31 August 2010 New 5, Updated 22, Retired 0, [Total 27]
Aknemycin Plus Active Ingredients / Generics: erythromycin, tretinoin Company: Almirall Limited New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Alvesco 40, 80 and 160 Inhaler Active Ingredients / Generics: ciclesonide Company: Nycomed UK Ltd \| Document History Improved Electronic Presentation
Captopril 12.5mg Tablets Active Ingredients / Generics: captopril Company: Goldshield plc \| Document History Change to section 4.9 - Overdose
Captopril 25mg Tablets Active Ingredients / Generics: captopril Company: Goldshield plc \| Document History Change to section 4.9 - Overdose
Condyline Active Ingredients / Generics: podophyllotoxin Company: Nycomed UK Ltd \| Document History Improved Electronic Presentation
Curatoderm Lotion Active Ingredients / Generics: tacalcitol monohydrate Company: Almirall Limited \| Document History Change to Marketing Authorisation Holder
DULCOLAX Suppositories for Children, 5mg Active Ingredients / Generics: bisacodyl Company: Boehringer Ingelheim Limited Consumer Healthcare \| Document History Change to section 5.1 - Pharmacodynamic Properties Change to section 5.2 - Pharmacokinetic Properties Change to section 10 date of revision of the text
Effentora 100, 200, 400 600 and 800 micrograms buccal tablets Active Ingredients / Generics: fentanyl citrate Company: Cephalon (UK) Limited \| Document History Change of manufacturer
Furadantin tablets 100mg Active Ingredients / Generics: nitrofurantoin Company: Goldshield plc New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Furadantin® tablets 50mg Active Ingredients / Generics: nitrofurantoin Company: Goldshield plc \| Document History Change to section 4.7 - Effects on Ability to Drive and Use Machines
Hydrea 500 mg Hard Capsules Active Ingredients / Generics: hydroxycarbamide Company: E. R. Squibb & Sons Limited \| Document History Change due to user-testing of patient information Change to name of manufacturer
Instanyl 50, 100 and 200 mcg/dose nasal spray Active Ingredients / Generics: fentanyl citrate Company: Nycomed UK Ltd \| Document History Improved Electronic Presentation
INTANZA 15 microgram/strain Active Ingredients / Generics: influenza vaccine Company: Sanofi Pasteur MSD Limited \| Document History Change to section 2 - Qualitative and quantitative composition
Loestrin Active Ingredients / Generics: ethinylestradiol, norethisterone acetate Company: Galen Limited \| Document History Change to date of revision Change to warnings or special precautions for use
Macrobid Capsules 100mg B.P. Active Ingredients / Generics: nitrofurantoin Company: Goldshield plc \| Document History Change to section 4.7 - Effects on Ability to Drive and Use Machines
Macrodantin Capsules 100mg B.P. Active Ingredients / Generics: nitrofurantoin Company: Goldshield plc \| Document History Change to section 4.7 - Effects on Ability to Drive and Use Machines
Macrodantin Capsules 50mg B.P. Active Ingredients / Generics: nitrofurantoin Company: Goldshield plc \| Document History Change to section 4.7 - Effects on Ability to Drive and Use Machines
Matrifen Active Ingredients / Generics: fentanyl Company: Nycomed UK Ltd \| Document History Improved Electronic Presentation
Pantoprazole 20 mg gastro-resistant Tablets Active Ingredients / Generics: pantoprazole sodium sesquihydrate Company: Nycomed UK Ltd \| Document History Improved Electronic Presentation
Pantoprazole 40 mg gastro-resistant Tablets Active Ingredients / Generics: pantoprazole sodium sesquihydrate Company: Nycomed UK Ltd \| Document History Improved Electronic Presentation
Phenindione 10mg tablets Active Ingredients / Generics: phenindione Company: Goldshield plc New SPC for new product
Phenindione 25mg tablets Active Ingredients / Generics: phenindione Company: Goldshield plc New SPC for new product
Procarbazine Capsules 50mg Active Ingredients / Generics: procarbazine hydrochloride Company: Alliance Pharmaceuticals \| Document History Change to section 7 - Marketing Authorisation Holder Change to section 8 - MARKETING AUTHORISATION NUMBER(S) Change to section 10 date of revision of the text
Protium 40 mg i.v. Powder for Solution for Injection Active Ingredients / Generics: pantoprazole sodium Company: Nycomed UK Ltd \| Document History Improved Electronic Presentation
TRIAMTERENE 50mg CAPSULES Active Ingredients / Generics: triamterene Company: Goldshield plc New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Tyverb Active Ingredients / Generics: lapatinib ditosylate monohydrate Company: GlaxoSmithKline UK \| Document History Improved Electronic Presentation
Vepesid Soft Capsules 50 mg and 100 mg Active Ingredients / Generics: etoposide Company: Bristol-Myers Pharmaceuticals \| Document History Change due to user-testing of patient information Change to name of manufacturer

02 September 2010

New 4, Updated 36, Retired 0, [Total 40]

Agrippal

Active Ingredients / Generics: influenza vaccine (surface antigen, inactivated)

Company: Novartis Vaccines | Document History

Change to section 2 - Qualitative and quantitative composition
Change to section 10 date of revision of the text

Beechams Active Cold Relief Caplets

Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams All in One Liquid (P)

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin

Company: GlaxoSmithKline Consumer Healthcare

New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Beechams All-in-One

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.7 - Effects on Ability to Drive and Use Machines
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams All-In-One Tablets

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams All-In-One Tablets (24s, P)

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, guaifenesin

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams Cold & Flu Hot Lemon and Honey

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c)

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams Cold and Flu Hot Blackcurrant

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c)

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams Decongestant Plus With Paracetamol

Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams Flu Plus Hot Lemon

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c)

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams Flu-Plus Caplets

Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams Flu-Plus Hot Berry Fruits

Active Ingredients / Generics: paracetamol, phenylephrine hydrochloride, ascorbic acid (vitamin c)

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Beechams Powders Capsules

Active Ingredients / Generics: paracetamol, caffeine, phenylephrine hydrochloride

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 10 date of revision of the text

Begrivac 2010/2011 suspension for injection in pre-filled syringe

Active Ingredients / Generics: influenza vaccine

Company: Novartis Vaccines | Document History

Change to section 2 - Qualitative and quantitative composition
Change to section 10 date of revision of the text

Calcichew 500mg Chewable Tablets

Active Ingredients / Generics: calcium carbonate

Company: Shire Pharmaceuticals Limited | Document History

Change to side-effects
Change to drug interactions

Calcichew D3 Chewable Tablets

Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3)

Company: Shire Pharmaceuticals Limited | Document History

Change to date of revision
Change to side-effects
Change to drug interactions

Calcichew D3 Forte Chewable Tablets

Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3)

Company: Shire Pharmaceuticals Limited | Document History

Change to side-effects
Change to drug interactions

Calcichew Forte Chewable Tablets

Active Ingredients / Generics: calcium carbonate

Company: Shire Pharmaceuticals Limited | Document History

Change to date of revision
Change to side-effects
Change to drug interactions

Captopril 50mg Tablets

Active Ingredients / Generics: captopril

Company: Goldshield plc | Document History

Change to section 4.9 - Overdose

DAKTARIN Sugar Free 2% Oral Gel

Active Ingredients / Generics: miconazole

Company: McNeil Ltd | Document History

Change to section 4.8 - Undesirable Effects
Change to section 10 date of revision of the text

Dihydrocodeine 30mg tablets

Active Ingredients / Generics: dihydrocodeine tartrate

Company: Goldshield plc

New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Dispersible Aspirin 75mg Tablets

Active Ingredients / Generics: aspirin

Company: Goldshield plc | Document History

Change to section 4.3 - Contraindications
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.6 - Pregnancy and Lactation
Change to section 4.8 - Undesirable Effects

Duphalac

Active Ingredients / Generics: lactulose

Company: Solvay Healthcare Limited | Document History

Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.6 - Pregnancy and Lactation
Change to section 5.3 - Preclinical Safety Data

Fluvirin

Active Ingredients / Generics: influenza vaccine (surface antigen, inactivated)

Company: Novartis Vaccines | Document History

Change to section 2 - Qualitative and quantitative composition
Change to section 10 date of revision of the text

Furosemide Tablets 500mg

Active Ingredients / Generics: furosemide

Company: Goldshield plc | Document History

Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.2 - Pharmacokinetic Properties

GARDASIL

Active Ingredients / Generics: human papillomavirus vaccine

Company: Sanofi Pasteur MSD Limited | Document History

Change to, or new, use for medicine

Haloperidol Injection BP 5mg/ml

Active Ingredients / Generics: haloperidol

Company: Goldshield plc | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.6 - Pregnancy and Lactation
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose

Helixate NexGen

Active Ingredients / Generics: octocog alfa

Company: CSL Behring UK Limited | Document History

Change to section 1 -Name of the Medicinal product
Change to section 2 - Qualitative and quantitative composition
Change to section 3 - Pharmaceutical form
Change to section 4.2 - Posology and method of administration
Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.6 - Pregnancy and Lactation
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 5.1 - Pharmacodynamic Properties
Change to section 6. 4 - Special Precautions for Storage
Change to section 6. 5 - Nature and Contents of Container
Change to section 6. 6 - Instructions for use, handling and disposal
Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Change to section 10 date of revision of the text

INTANZA 9 microgram/strain

Active Ingredients / Generics: influenza vaccine (split virion, inactivated)

Company: Sanofi Pasteur MSD Limited

New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Intrinsa 300 micrograms/24 hours transdermal patch

Active Ingredients / Generics: testosterone

Company: Warner Chilcott UK Limited | Document History

Change to section 7 - Marketing Authorisation Holder
Change to section 10 date of revision of the text

Metoclopramide 10mg Tablets

Active Ingredients / Generics: metoclopramide hydrochloride

Company: Goldshield plc

New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Nexavar 200mg film-coated tablets

Active Ingredients / Generics: sorafenib tosilate

Company: Bayer plc | Document History

Change to section 2 - Qualitative and quantitative composition
Change to section 4.2 - Posology and method of administration
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.6 - Pregnancy and Lactation
Change to section 4.8 - Undesirable Effects
Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.2 - Pharmacokinetic Properties
Change to section 6.1 - List of Excipients
Change to section 6. 6 - Instructions for use, handling and disposal
Change to section 10 date of revision of the text

Ondansetron 4mg film-coated tablets

Active Ingredients / Generics: ondansetron hydrochloride dihydrate

Company: Goldshield plc | Document History

Change to section 4.1 - Therapeutic indications
Change to section 4.2 - Posology and method of administration
Change to section 4.4 - Special warnings and precautions for Use
Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.2 - Pharmacokinetic Properties

Ondansetron 8mg film-coated tablets

Active Ingredients / Generics: ondansetron hydrochloride dihydrate

Company: Goldshield plc | Document History

Change to section 4.1 - Therapeutic indications
Change to section 4.2 - Posology and method of administration
Change to section 4.4 - Special warnings and precautions for Use
Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.2 - Pharmacokinetic Properties

Pandemrix suspension and emulsion for emulsion for injection

Active Ingredients / Generics: influenza vaccine (split virion, inactivated)

Company: GlaxoSmithKline UK | Document History

Correction of spelling/typing errors

Slozem 120mg, 180mg, 240mg, 300mg Capsules

Active Ingredients / Generics: diltiazem hydrochloride

Company: Merck Serono | Document History

Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects

Solpadeine Plus Tablets

Active Ingredients / Generics: paracetamol, caffeine, codeine phosphate hemihydrate

Company: GlaxoSmithKline Consumer Healthcare | Document History

Change to section 6.1 - List of Excipients
Change to section 10 date of revision of the text

Tarceva 25mg, 100mg and 150mg Film-Coated Tablets

Active Ingredients / Generics: erlotinib hydrochloride

Company: Roche Products Limited | Document History

Change to section 6. 3 - Shelf Life
Change to section 10 date of revision of the text

Warfarin 1, 3 & 5mg tablets

Active Ingredients / Generics: warfarin sodium

Company: Goldshield plc | Document History

Change to date of revision
Change of manufacturer
Change of contra-indications
Change to side-effects
Change to drug interactions
Change to information about pregnancy or lactation
Change to name of manufacturer

Zinacef

Active Ingredients / Generics: cefuroxime sodium

Company: GlaxoSmithKline UK | Document History

Change to date of revision
Change to warnings or special precautions for use
Change due to user-testing of patient information

01 September 2010

New 0, Updated 31, Retired 0, [Total 31]

Bricanyl Respules 2.5 mg/ml Nebuliser Solution

Active Ingredients / Generics: terbutaline sulphate

Company: AstraZeneca UK Limited | Document History

Correction of spelling/typing errors

Calcichew 500mg Chewable Tablets

Active Ingredients / Generics: calcium carbonate

Company: Shire Pharmaceuticals Limited | Document History

Change to section 4.2 - Posology and method of administration
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose

Calcichew D3 Chewable Tablets

Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3)

Company: Shire Pharmaceuticals Limited | Document History

Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose

Calcichew D3 Forte Chewable Tablets

Active Ingredients / Generics: calcium carbonate, colecalciferol (vitamin d3)

Company: Shire Pharmaceuticals Limited | Document History

Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose

Calcichew Forte Chewable Tablets

Active Ingredients / Generics: calcium carbonate

Company: Shire Pharmaceuticals Limited | Document History

Change to section 4.2 - Posology and method of administration
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose

Clomid

Active Ingredients / Generics: clomifene citrate

Company: sanofi-aventis | Document History

Change to side-effects

Clomid

Active Ingredients / Generics: clomifene citrate

Company: sanofi-aventis | Document History

Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.8 - Undesirable Effects

Daktarin Oral Gel

Active Ingredients / Generics: miconazole

Company: Janssen-Cilag Ltd | Document History

Change to section 4.8 - Undesirable Effects
Change to section 10 date of revision of the text

Daunorubicin

Active Ingredients / Generics: daunorubicin hydrochloride

Company: Winthrop Pharmaceuticals UK Ltd | Document History

Change to side-effects
Change to drug interactions
Change to information about pregnancy or lactation
Change to information about driving or using machinery

Daunorubicin

Active Ingredients / Generics: daunorubicin hydrochloride

Company: Winthrop Pharmaceuticals UK Ltd | Document History

Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.6 - Pregnancy and Lactation
Change to section 4.7 - Effects on Ability to Drive and Use Machines
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose

DULCOLAX Suppositories, 10 mg

Active Ingredients / Generics: bisacodyl

Company: Boehringer Ingelheim Limited Consumer Healthcare | Document History

Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.2 - Pharmacokinetic Properties
Change to section 10 date of revision of the text

DULCOLAX Tablets, 5 mg (GSL)

Active Ingredients / Generics: bisacodyl

Company: Boehringer Ingelheim Limited Consumer Healthcare | Document History

Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.2 - Pharmacokinetic Properties
Change to section 10 date of revision of the text

DULCOLAX Tablets, 5mg

Active Ingredients / Generics: bisacodyl

Company: Boehringer Ingelheim Limited Consumer Healthcare | Document History

Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.2 - Pharmacokinetic Properties
Change to section 10 date of revision of the text

GARDASIL

Active Ingredients / Generics: human papillomavirus vaccine

Company: Sanofi Pasteur MSD Limited | Document History

Change to section 4.1 - Therapeutic indications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.6 - Pregnancy and Lactation
Change to section 5.1 - Pharmacodynamic Properties

Kivexa film-coated tablets

Active Ingredients / Generics: lamivudine, abacavir sulfate

Company: ViiV Healthcare UK Ltd | Document History

Change to Marketing Authorisation Holder
Change to manufacturer contact details

Loestrin 20

Active Ingredients / Generics: ethinylestradiol, norethisterone acetate

Company: Galen Limited | Document History

Change to section 4.4 - Special warnings and precautions for Use

Loestrin 30

Active Ingredients / Generics: ethinylestradiol, norethisterone acetate

Company: Galen Limited | Document History

Change to section 4.4 - Special warnings and precautions for Use

Nexavar 200mg film-coated tablets

Active Ingredients / Generics: sorafenib tosilate

Company: Bayer plc | Document History

Change to date of revision
Change to warnings or special precautions for use
Change of contra-indications
Change to side-effects, Extra statutory information

Perinal Cutaneous Spray

Active Ingredients / Generics: hydrocortisone, lidocaine hydrochloride

Company: Dermal Laboratories Limited | Document History

Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Change to section 10 date of revision of the text

Priadel 200mg & 400mg prolonged release tablets

Active Ingredients / Generics: lithium carbonate

Company: sanofi-aventis | Document History

Change to section 5.2 - Pharmacokinetic Properties

Priadel Liquid

Active Ingredients / Generics: lithium citrate

Company: sanofi-aventis | Document History

Change to section 5.2 - Pharmacokinetic Properties

Resolor 1mg and 2mg film-coated tablets

Active Ingredients / Generics: prucalopride succinate

Company: Movetis Ltd | Document History

Change to Further Information section
Change to date of revision
Change to manufacturer contact details

Resolor 1mg film-coated tablets

Active Ingredients / Generics: prucalopride succinate

Company: Movetis Ltd | Document History

Change to section 6. 5 - Nature and Contents of Container
Change to section 7 - Marketing Authorisation Holder
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
Change to section 10 date of revision of the text

Resolor 2mg film-coated tablets

Active Ingredients / Generics: prucalopride succinate

Company: Movetis Ltd | Document History

Change to section 6. 5 - Nature and Contents of Container
Change to section 7 - Marketing Authorisation Holder
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
Change to section 10 date of revision of the text

Scheriproct Ointment

Active Ingredients / Generics: prednisolone hexanoate, cinchocaine hydrochloride

Company: Bayer plc | Document History

Removal/change of distributor

Scheriproct Suppositories

Active Ingredients / Generics: prednisolone hexanoate, cinchocaine hydrochloride

Company: Bayer plc | Document History

Removal/change of distributor

Skinoren Cream

Active Ingredients / Generics: azelaic acid

Company: Bayer plc | Document History

Removal/change of distributor

Ultrabase

Active Ingredients / Generics: No Active Ingredients

Company: Bayer plc | Document History

Removal/change of distributor

Vascace Tablets

Active Ingredients / Generics: cilazapril monohydrate

Company: Roche Products Limited | Document History

Change to section 4.1 - Therapeutic indications
Change to section 4.2 - Posology and method of administration
Change to section 4.3 - Contraindications
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.6 - Pregnancy and Lactation
Change to section 4.7 - Effects on Ability to Drive and Use Machines
Change to section 4.8 - Undesirable Effects
Change to section 4.9 - Overdose
Change to section 5.1 - Pharmacodynamic Properties
Change to section 5.3 - Preclinical Safety Data

Zeffix 100mg film-coated tablets

Active Ingredients / Generics: lamivudine

Company: GlaxoSmithKline UK | Document History

Change to section 4.1 - Therapeutic indications
Change to section 4.2 - Posology and method of administration
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.6 - Pregnancy and Lactation
Change to section 5.1 - Pharmacodynamic Properties
Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Change to section 10 date of revision of the text

Zeffix 5mg/ml oral solution

Active Ingredients / Generics: lamivudine

Company: GlaxoSmithKline UK | Document History

Change to section 4.1 - Therapeutic indications
Change to section 4.2 - Posology and method of administration
Change to section 4.4 - Special warnings and precautions for Use
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Change to section 4.6 - Pregnancy and Lactation
Change to section 5.1 - Pharmacodynamic Properties
Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Change to section 10 date of revision of the text

31 August 2010

New 5, Updated 22, Retired 0, [Total 27]